Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Irina Nordkin, Tatyana Levinas, Inna Rosenfeld, Majdi Halabi

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.

Original languageEnglish
Pages (from-to)391-394
Number of pages4
JournalClinical Case Reports
Volume9
Issue number1
DOIs
StatePublished - Jan 2021

Bibliographical note

Publisher Copyright:
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Keywords

  • QT prolongation
  • amiodarone
  • atrial fibrillation
  • torsades de Pointes

Fingerprint

Dive into the research topics of 'Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation'. Together they form a unique fingerprint.

Cite this